MyFinsight
Home
Blog
About
Stock-based compensation
expense
$25,616K
(-56.31%↓ Y/Y)
Issuance of common stock
from exercise of...
$3,016K
(-23.53%↓ Y/Y)
Other receivables
-$14,018K
(-120.47%↓ Y/Y)
Depreciation and
amortization
$9,664K
(-38.98%↓ Y/Y)
Fair value
adjustments on contingent...
-$3,523K
Accounts payable
$3,290K
(-5.68%↓ Y/Y)
Accrued compensation
and other related...
$3,123K
(139.95%↑ Y/Y)
Inventory
-$3,001K
(80.10%↑ Y/Y)
Non-cash lease expense
$2,016K
Prepaid expenses and
other current assets
-$1,206K
(-262.75%↓ Y/Y)
Other noncurrent
liabilities
$140K
(-86.54%↓ Y/Y)
Net cash provided by
operating activities
$16,974K
(-67.39%↓ Y/Y)
Net cash provided by
(used in) financing...
$3,016K
(-23.53%↓ Y/Y)
Canceled cashflow
$48,623K
Net increase in cash
and cash...
$12,227K
(-77.21%↓ Y/Y)
Canceled cashflow
$7,763K
Net income (loss)
-$17,931K
(-10061.67%↓ Y/Y)
Other noncurrent
assets
$12,205K
(600.41%↑ Y/Y)
Accounts receivable
$8,514K
(122.45%↑ Y/Y)
Accrued expenses and
other current...
-$3,558K
(-23.07%↓ Y/Y)
Operating lease liability
-$2,972K
(40.39%↑ Y/Y)
Deferred revenue
-$1,586K
(-246.29%↓ Y/Y)
Deferred income taxes
-$1,434K
Other
-$423K
(54.32%↑ Y/Y)
Proceeds from maturities
of marketable...
$25,000K
(-50.00%↓ Y/Y)
Net cash used in
investing activities
-$7,735K
(-173.13%↓ Y/Y)
Effect of exchange
rates changes on cash...
-$28K
(-105.91%↓ Y/Y)
Canceled cashflow
$25,000K
Purchases of marketable
securities
$24,546K
(-50.27%↓ Y/Y)
Business combination
$6,101K
Purchases of property and
equipment
$1,588K
(-54.25%↓ Y/Y)
Purchase of equity
interest rights
$500K
Back
Back
Cash Flow
10x Genomics, Inc. (TXG)
10x Genomics, Inc. (TXG)
source: myfinsight.com